UK Medtech's US Innovation Hub Aims To Accentuate The Positive In Post-Brexit Phase
Executive Summary
With Brexit moving ever closer, the UK medtech industry is trying to ensure that local manufacturers have a range of commercial options in overseas markets in the post-EU phase. The ABHI is playing a strong support role in this area, following up its recent international growth plan with a new US innovation hub, designed to offer outward-looking UK medtechs the tools to build positions in the world's largest market.
You may also be interested in...
UK Medtech Industry Advances Its Case For US FTA Amid Ongoing EU Talks
Securing a favorable post-Brexit free trade agreement with the US is the principal aim of the UK’s Department for International Trade, and the UK medtech industry is pressing its case for closer business links with its largest non-EU trading partner.
UK Medtech Upscales International Plans Ahead of Brexit
As the UK prepared to leave the EU, the local medtech industry, represented by the Association of British Healthcare Industries, has been busy finding ways to make up for any potential restrictions on market access and business development. On June 21, it announced a three-year growth plan, as explained by ABHI managing director of international Paul Benton in this Medtech Insight podcast interview.
UK Medtech Rises Up To Meet The Challenges Of Brexit
How the UK medtech industry can forge successful international relationships, increase health-care delivery efficiency and improve patient outcomes following Brexit are the challenges taken up by the Association of British Healthcare Industries in a new report.